These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7334916)

  • 21. Radioligand binding using 125I-labeled peptides.
    Abel PW; Waugh D; Jeffries WB
    Methods Mol Biol; 1997; 73():323-9. PubMed ID: 9031219
    [No Abstract]   [Full Text] [Related]  

  • 22. Folate and its reduced forms labeled with deuterium at carbon-7.
    Pastore EJ
    Methods Enzymol; 1980; 66():538-41. PubMed ID: 7374496
    [No Abstract]   [Full Text] [Related]  

  • 23. [Advances in the preparation of 125I-labeled polypeptides, up to 11 amino acids, as RIA-tracers].
    Schmidt HE
    Radiobiol Radiother (Berl); 1984; 25(3):481-7. PubMed ID: 6473749
    [No Abstract]   [Full Text] [Related]  

  • 24. Preparation of biologically intact radioiodinated hyaluronan of high specific radioactivity: coupling of 125I-tyramine-cellobiose to amino groups after partial N-deacetylation.
    Dahl LB; Laurent TC; Smedsrød B
    Anal Biochem; 1988 Dec; 175(2):397-407. PubMed ID: 3071184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and preclinical evaluation of a folic acid derivative labeled with 18F for PET imaging of folate receptor-positive tumors.
    Bettio A; Honer M; Müller C; Brühlmeier M; Müller U; Schibli R; Groehn V; Schubiger AP; Ametamey SM
    J Nucl Med; 2006 Jul; 47(7):1153-60. PubMed ID: 16818950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts.
    Reist CJ; Archer GE; Kurpad SN; Wikstrand CJ; Vaidyanathan G; Willingham MC; Moscatello DK; Wong AJ; Bigner DD; Zalutsky MR
    Cancer Res; 1995 Oct; 55(19):4375-82. PubMed ID: 7671250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and characterization of an 125I-labeled Sendai virus ligand.
    McDonald HC; Luderer AA; Hess DM; Credle L
    Anal Biochem; 1980 Jul; 106(1):127-33. PubMed ID: 6158276
    [No Abstract]   [Full Text] [Related]  

  • 28. Thin-layer chromatography of pteroylmonoglutamates and related compounds.
    Scott JM
    Methods Enzymol; 1980; 66():437-43. PubMed ID: 7374484
    [No Abstract]   [Full Text] [Related]  

  • 29. High-affinity folate receptor in human ovary, serous ovarian adenocarcinoma, and ascites: radioligand binding mechanism, molecular size, ionic properties, hydrophobic domain, and immunoreactivity.
    Holm J; Hansen SI; Høier-Madsen M; Birn H; Helkjaer PE
    Arch Biochem Biophys; 1999 Jun; 366(2):183-91. PubMed ID: 10356282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiolabelled peptides: now and the future.
    Thakur ML
    Nucl Med Commun; 1995 Sep; 16(9):724-32. PubMed ID: 7478404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular simulation of ligand-binding with DNA: implications for 125I-labeled pharmaceutical design.
    Chen K; Adelstein SJ; Kassis AI
    Int J Radiat Biol; 2004; 80(11-12):921-6. PubMed ID: 15764403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kit formulation for the preparation of radiolabeled iododeoxyuridine by demetallation.
    Foulon CF; Adelstein SJ; Kassis AI
    J Nucl Med; 1996 Apr; 37(4 Suppl):1S-3S. PubMed ID: 8676193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Simplified method for the preparation of I-131 iodothalmate].
    Sierra Ordornez P; Alvarez Cervera J
    Prensa Med Mex; 1974; 39(5-6):259-61. PubMed ID: 4438233
    [No Abstract]   [Full Text] [Related]  

  • 34. [Isolation and purification of lactoperoxidase and its application to the radio-iodination of IgG].
    Zhao WS; Fu LC; Wang SZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982; 4(2):101-4. PubMed ID: 6216003
    [No Abstract]   [Full Text] [Related]  

  • 35. Methods of labelling radiopharmaceuticals.
    Lyster DM
    Can J Hosp Pharm; 1976; 29(6):183-4. PubMed ID: 10235978
    [No Abstract]   [Full Text] [Related]  

  • 36. Preparation of tritiated dihydrofolic acid of high specific activity.
    Zakrzewski SF
    Methods Enzymol; 1980; 66():529-33. PubMed ID: 7374494
    [No Abstract]   [Full Text] [Related]  

  • 37. Folate concentrations and folic acid supplementation among women in their first trimester of pregnancy in a rural area with a high prevalence of neural tube defects in Shanxi, China.
    Zhang L; Ren A; Li Z; Hao L; Tian Y; Li Z
    Birth Defects Res A Clin Mol Teratol; 2006 Jun; 76(6):461-6. PubMed ID: 16933216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defect in the method for 125I-labeled folate radioassays.
    Zaidman JL; Clejeanu L
    Clin Chem; 1977 Feb; 23(2 PT. 1):304-5. PubMed ID: 832406
    [No Abstract]   [Full Text] [Related]  

  • 39. The preparation of iodine-123 labelled contrast agents.
    Thakur ML
    Int J Appl Radiat Isot; 1974 Dec; 25(11-12):576-8. PubMed ID: 4443106
    [No Abstract]   [Full Text] [Related]  

  • 40. [Radioisotope labelling of the plasmatic activator of plasminogen].
    Díaz A; Claro A
    Sangre (Barc); 1982; 27(4A):479-84. PubMed ID: 6891503
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.